Total Payments
$95,119
2023 Payments
$25.51
Companies
14
Transactions
137
Medicare Patients
1,867
Medicare Billing
$394,058
Payment Breakdown by Category
Other$85,460 (89.8%)
Travel$3,325 (3.5%)
Consulting$3,250 (3.4%)
Food & Beverage$3,069 (3.2%)
Education$14.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,460 | 45 | 89.8% |
| Travel and Lodging | $3,325 | 11 | 3.5% |
| Consulting Fee | $3,250 | 6 | 3.4% |
| Food and Beverage | $3,069 | 74 | 3.2% |
| Education | $14.90 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $53,689 | 63 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33,844 | 44 | $0 (2021) |
| PFIZER INC. | $6,996 | 9 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $261.54 | 2 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $96.41 | 5 | $0 (2023) |
| Genentech USA, Inc. | $54.32 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $49.20 | 4 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $27.22 | 1 | $0 (2020) |
| Mallinckrodt LLC | $22.13 | 1 | $0 (2018) |
| Philips Electronics North America Corporation | $18.21 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25.51 | 1 | Janssen Scientific Affairs, LLC ($25.51) |
| 2021 | $3,359 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,909) |
| 2020 | $2,537 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,134) |
| 2019 | $33,090 | 38 | Janssen Pharmaceuticals, Inc ($16,734) |
| 2018 | $28,896 | 43 | Janssen Pharmaceuticals, Inc ($13,598) |
| 2017 | $27,211 | 40 | Janssen Pharmaceuticals, Inc ($22,531) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/06/2023 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $570.00 | General |
| 10/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $570.00 | General |
| 08/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $570.00 | General |
| 08/05/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $570.00 | General |
| 06/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $570.00 | General |
| 12/17/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| 11/09/2020 | BOSTON SCIENTIFIC CORPORATION | SPACEOAR VUE (Device) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: BPH | ||||||
| 10/29/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| 08/21/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| 07/14/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $75.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $49.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/05/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $16.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $87.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 413 | 629 | $256,060 | $81,701 |
| 2022 | 10 | 467 | 675 | $270,286 | $88,925 |
| 2021 | 11 | 463 | 672 | $272,492 | $92,720 |
| 2020 | 10 | 524 | 869 | $401,931 | $130,711 |
Total Patients
1,867
Total Services
2,845
Medicare Billing
$394,058
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 108 | 273 | $167,622 | $50,613 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 69 | $33,506 | $10,500 | 31.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 99 | $26,082 | $10,094 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 57 | $16,572 | $6,414 | 38.7% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 21 | 21 | $8,736 | $3,255 | 37.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 27 | 27 | $1,248 | $250.56 | 20.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 39 | 39 | $858.00 | $245.36 | 28.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 28 | 28 | $892.00 | $194.00 | 21.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 16 | 16 | $544.00 | $134.55 | 24.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 116 | 291 | $178,674 | $56,009 | 31.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 93 | 93 | $45,184 | $15,108 | 33.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 94 | $23,500 | $8,613 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 40 | $10,632 | $4,330 | 40.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $5,648 | $2,695 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $2,610 | $1,125 | 43.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 57 | 58 | $1,276 | $410.77 | 32.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 26 | 26 | $1,300 | $278.15 | 21.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 27 | 27 | $918.00 | $207.16 | 22.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 16 | 16 | $544.00 | $146.96 | 27.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 123 | 294 | $180,516 | $57,808 | 32.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 89 | 90 | $43,733 | $16,345 | 37.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 66 | 78 | $19,500 | $7,111 | 36.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 38 | $9,994 | $4,355 | 43.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 23 | $8,119 | $3,435 | 42.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 26 | $4,498 | $1,699 | 37.8% |
About Dr. Chee Chan, MD
Dr. Chee Chan, MD is a Internal Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912093618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chee Chan, MD has received a total of $95,119 in payments from pharmaceutical and medical device companies, with $25.51 received in 2023. These payments were reported across 137 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($85,460).
As a Medicare-enrolled provider, Chan has provided services to 1,867 Medicare beneficiaries, totaling 2,845 services with total Medicare billing of $394,058. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Washington, DC
- Active Since 10/04/2006
- Last Updated 10/21/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912093618
Products in Payments
- XARELTO (Drug) $53,785
- ELIQUIS (Drug) $7,257
- SPIRIVA (Drug) $1,410
- SPIRIVA RESPIMAT (Drug) $131.79
- STIOLTO RESPIMAT (Drug) $87.25
- STIOLTO (Drug) $47.70
- SYMBICORT (Drug) $37.03
- Esbriet (Biological) $34.80
- SPACEOAR VUE (Device) $27.22
- ACTHAR (Biological) $22.13
- Xolair (Biological) $19.52
- Wellcentive Undiv (Device) $18.21
- TUDORZA PRESSAIR (Drug) $16.90
- AFREZZA (Drug) $16.38
- BROVANA (Drug) $14.50
- ANORO (Drug) $13.66
- FASENRA (Drug) $12.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Washington
Lawrence Dubuske, M.d, M.D
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Kavita Patel, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Andrea Singer
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Theo Hodge, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Ashte Collins, M.d, M.D
Internal Medicine — Payments: $837,513
Internal Medicine $837,513
Manish Shah, Md, MD
Internal Medicine — Payments: $456,731
Internal Medicine $456,731